Rigel Pharmaceuticals (RIGL) Research & Development: 2009-2025
Historic Research & Development for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Sep 2025 value amounting to $7.4 million.
- Rigel Pharmaceuticals' Research & Development rose 18.94% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 million, marking a year-over-year increase of 34.91%. This contributed to the annual value of $23.4 million for FY2024, which is 4.66% down from last year.
- Latest data reveals that Rigel Pharmaceuticals reported Research & Development of $7.4 million as of Q3 2025, which was up 7.80% from $6.8 million recorded in Q2 2025.
- In the past 5 years, Rigel Pharmaceuticals' Research & Development ranged from a high of $18.3 million in Q3 2021 and a low of $3.2 million during Q4 2023.
- Its 3-year average for Research & Development is $6.4 million, with a median of $6.2 million in 2024.
- In the last 5 years, Rigel Pharmaceuticals' Research & Development plummeted by 79.26% in 2023 and then soared by 76.77% in 2024.
- Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Research & Development stood at $13.3 million in 2021, then increased by 15.49% to $15.4 million in 2022, then crashed by 79.26% to $3.2 million in 2023, then skyrocketed by 76.77% to $5.6 million in 2024, then rose by 18.94% to $7.4 million in 2025.
- Its Research & Development was $7.4 million in Q3 2025, compared to $6.8 million in Q2 2025 and $8.4 million in Q1 2025.